130 related articles for article (PubMed ID: 8031454)
1. Psoralen--lexitropsin hybrids: DNA sequence selectivity of photoinduced cross-linking from MPE footprinting and exonuclease III stop assay, and mode of binding from electric linear dichroism.
Rao KE; Gosselin G; Mrani D; Périgaud C; Imbach JL; Bailly C; Hénichart JP; Colson P; Houssier C; Lown JW
Anticancer Drug Des; 1994 Jun; 9(3):221-37. PubMed ID: 8031454
[TBL] [Abstract][Full Text] [Related]
2. Quantitative footprinting analysis of drug-DNA interactions: Fe(III) methidium-propyl-EDTA as a probe.
Dabrowiak JC; Kissinger K; Goodisman J
Electrophoresis; 1989; 10(5-6):404-12. PubMed ID: 2548840
[TBL] [Abstract][Full Text] [Related]
3. Molecular recognition between oligopeptides and nucleic acids. Specificity of binding of a monocationic bis-furan lexitropsin to DNA deduced from footprinting and 1H NMR studies.
Lee M; Krowicki K; Shea RG; Lown JW; Pon RT
J Mol Recognit; 1989 Sep; 2(2):84-93. PubMed ID: 2561528
[TBL] [Abstract][Full Text] [Related]
4. Molecular recognition between oligopeptides and nucleic acids: DNA sequence specificity and binding properties of thiazole-lexitropsins incorporating the concepts of base site acceptance and avoidance.
Rao KE; Shea RG; Yadagiri B; Lown JW
Anticancer Drug Des; 1990 Feb; 5(1):3-20. PubMed ID: 2156516
[TBL] [Abstract][Full Text] [Related]
5. Molecular and cellular pharmacology of novel photoactive psoralen and coumarin conjugates of pyrrole- and imidazole-containing analogues of netropsin.
Hartley JA; McAdam SR; Das S; Roldan MC; Haskell MK; Lee M
Anticancer Drug Des; 1994 Jun; 9(3):181-97. PubMed ID: 8031451
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, DNA-binding and cytotoxic properties of a bis(netropsin)-anthracenedione conjugate.
Boitte N; Pommery N; Colson P; Houssier C; Waring MJ; Hénichart JP; Bailly C
Anticancer Drug Des; 1997 Sep; 12(6):481-501. PubMed ID: 9311557
[TBL] [Abstract][Full Text] [Related]
7. DNA sequence-selective binding of head-to-tail linked bis-lexitropsins: relation of phasing to cytotoxic potency.
Guo D; Gupta R; Lown JW
Anticancer Drug Des; 1993 Oct; 8(5):369-97. PubMed ID: 8251044
[TBL] [Abstract][Full Text] [Related]
8. Molecular recognition between oligopeptides and nucleic acids. DNA sequence specificity and binding properties of an acridine-linked netropsin hybrid ligand.
Bailly C; Helbecque N; Hénichart JP; Colson P; Houssier C; Rao KE; Shea RG; Lown JW
J Mol Recognit; 1990 Feb; 3(1):26-35. PubMed ID: 2354061
[TBL] [Abstract][Full Text] [Related]
9. Influence of the methyl substituents of a thiazole-containing lexitropsin on the mode of binding to DNA.
Plouvier B; Houssin R; Helbecque N; Colson P; Houssier C; Hénichart JP; Bailly C
Anticancer Drug Des; 1995 Mar; 10(2):155-66. PubMed ID: 7710636
[TBL] [Abstract][Full Text] [Related]
10. Identification of the template-binding cleft of T7 RNA polymerase as the site for promoter binding by photochemical cross-linking with psoralen.
Sastry SS
Biochemistry; 1996 Oct; 35(42):13519-30. PubMed ID: 8885831
[TBL] [Abstract][Full Text] [Related]
11. DNA binding of a short lexitropsin.
Anthony NG; Fox KR; Johnston BF; Khalaf AI; Mackay SP; McGroarty IS; Parkinson JA; Skellern GG; Suckling CJ; Waigh RD
Bioorg Med Chem Lett; 2004 Mar; 14(5):1353-6. PubMed ID: 14980697
[TBL] [Abstract][Full Text] [Related]
12. In vitro photoinduced cytotoxicity and DNA binding properties of psoralen and coumarin conjugates of netropsin analogues: DNA sequence-directed alkylation and cross-link formation.
Lee M; Roldan MC; Haskell MK; McAdam SR; Hartley JA
J Med Chem; 1994 Apr; 37(8):1208-13. PubMed ID: 8164263
[TBL] [Abstract][Full Text] [Related]
13. Short lexitropsin that recognizes the DNA minor groove at 5'-ACTAGT-3': understanding the role of isopropyl-thiazole.
Anthony NG; Johnston BF; Khalaf AI; MacKay SP; Parkinson JA; Suckling CJ; Waigh RD
J Am Chem Soc; 2004 Sep; 126(36):11338-49. PubMed ID: 15355117
[TBL] [Abstract][Full Text] [Related]
14. Carbocyclic analogues of lexitropsin--DNA affinity and endonuclease inhibition.
Pućkowska A; Drozdowska D; Midura-Nowaczek K
Acta Pol Pharm; 2007; 64(2):115-9. PubMed ID: 17665860
[TBL] [Abstract][Full Text] [Related]
15. DNA recognition by lexitropsins, minor groove binding agents.
Lown JW
J Mol Recognit; 1994 Jun; 7(2):79-88. PubMed ID: 7826677
[TBL] [Abstract][Full Text] [Related]
16. Copper-dependent oxidative and topoisomerase II-mediated DNA cleavage by a netropsin/4'-(9-acridinylamino)methanesulfon-m-anisidide combilexin.
Henichart JP; Waring MJ; Riou JF; Denny WA; Bailly C
Mol Pharmacol; 1997 Mar; 51(3):448-61. PubMed ID: 9058600
[TBL] [Abstract][Full Text] [Related]
17. Molecular determinants for DNA minor groove recognition: design of a bis-guanidinium derivative of ethidium that is highly selective for AT-rich DNA sequences.
Bailly C; Arafa RK; Tanious FA; Laine W; Tardy C; Lansiaux A; Colson P; Boykin DW; Wilson WD
Biochemistry; 2005 Feb; 44(6):1941-52. PubMed ID: 15697219
[TBL] [Abstract][Full Text] [Related]
18. Design of composite drug molecules: mutual effects on binding to DNA of an intercalator, amsacrine, and a minor groove binder, netropsin.
Bourdouxhe C; Colson P; Houssier C; Hénichart JP; Waring MJ; Denny WA; Bailly C
Anticancer Drug Des; 1995 Mar; 10(2):131-54. PubMed ID: 7710635
[TBL] [Abstract][Full Text] [Related]
19. Thermodynamic data from drug-DNA footprinting experiments.
Dabrowiak JC; Goodisman J; Kissinger K
Biochemistry; 1990 Jul; 29(26):6139-45. PubMed ID: 2169863
[TBL] [Abstract][Full Text] [Related]
20. Sequence-selective interaction of the minor-groove interstrand cross-linking agent SJG-136 with naked and cellular DNA: footprinting and enzyme inhibition studies.
Martin C; Ellis T; McGurk CJ; Jenkins TC; Hartley JA; Waring MJ; Thurston DE
Biochemistry; 2005 Mar; 44(11):4135-47. PubMed ID: 15766241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
